Tata India Pharma & Healthcare Fund-Direct Plan-Growth

As on 23 Oct 2026

logo

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Equity

NAV

₹ 35.75

CAGR (3 Years)

16.81%

AUM (Cr)

₹ 1,511.49

Risk

Very High Risk

About Tata India Pharma & Healthcare Fund-Direct Plan-Growth

To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.

Breakdown of this Fund

logo
Agro Chemicals
12.48%
logo
Chemicals
2.59%
logo
Debt Others
0.79%
logo
FMCG
2.32%
logo
Healthcare
59.88%
logo
Insurance
0.50%
logo
Pharmaceuticals
85.62%

Market Capitalization

Get your FAQs right

What kind of returns does Tata India Pharma & Healthcare Fund-Direct Plan-Growth provide?

plus

How much expense ratio is charged by Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the AUM of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the PE and PB ratio of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the exit load of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions